Biltstraat 106

3572 BJ, Utrecht, the Netherlands

info@virology-education.com

  • White Twitter Icon
  • White LinkedIn Icon
  • White Facebook Icon

Tel: +31 (0)30 230 7140
Fax: +31 (0)30 230 7148

© 2020 by Virology Education

Enduring Materials

Tendani Gaolathe, MD

Clinical case: Researcher perspective

button_slides.png
button_video.png

Botswana Harvard AIDS Institute Partnership, Botswana

Session 1: Current controversies for cART use in women of child bearing potential and in pregnancy

Lucy Wanjiku Njenga

Clinical case: Community perspective

button_video.png

Positive Young Women Voices, Kenya

Session 1: Current controversies for cART use in women of child bearing potential and in pregnancy

Meg Doherty, MD, PhD

Clinical case: Policy implications

button_slides.png
button_video.png

WHO, UK

Session 1: Current controversies for cART use in women of child bearing potential and in pregnancy

Jessica Albano, PhD, MPH

INSTI exposure and neural tube defects – data from antiretroviral pregnancy registry

button_slides.png

Syneos Health, USA

ABSTRACT

Session 1: Current controversies for cART use in women of child bearing potential and in pregnancy

Deborah Money, MD

Congenital anomalies in infants of Canadian women exposed to antiretrovirals including dolutegravir

button_slides.png

UBC, Canada

ABSTRACT

Session 1: Current controversies for cART use in women of child bearing potential and in pregnancy

Hala Shamsuddin, MD

Evaluation of neural tube defects after exposure to Raltegravir during pregnancy

button_slides.png

Merck, USA

ABSTRACT

Session 1: Current controversies for cART use in women of child bearing potential and in pregnancy

Annemiek de Ruiter, MBBS FRCP, MD

Invited lecture, focus on cabotegravir

ViiV Healthcare, UK

Session 2: New drug delivery systems, are they right for women?

Kimberly Scarsi, PharmD, MS

Emerging drug delivery systems for treatment and prevention of HIV

button_slides.png
button_video.png

University of Nebraska, USA

Session 2: New drug delivery systems, are they right for women?

Kimberly Adkison, PhD

Clinical development strategy to inform dosing of antiretroviral drugs in women: dolutegravir as a case study

button_slides.png

Viiv Healthcare, USA

ABSTRACT

Session 2: New drug delivery systems, are they right for women?

Jill Blumenthal, MD

HIV risk and characteristics of women seeking PrEP in a US demonstration project

button_slides.png

University of California, San Diago, USA

ABSTRACT

Session 2: New drug delivery systems, are they right for women?

Not available due to confidentiality

Session 3: Unique challenges of growing up with HIV

Lynn Matthews, MD

High PrEP uptake among HIV-exposed women with pregnancy plans in South Africa

button_slides.png

University of Alabama at Birmingham, USA

ABSTRACT

Session 3: Unique challenges of growing up with HIV

Elizabeth Okoth (presented by N. Rakhmanina), MPH

Innovative intervention for pregnant and breastfeeding adolescent mothers to enhance viral suppression in Homa Bay County, Kenya

button_slides.png

Elizabeth Glaser Pediatric AIDS Foundation, Kenya

ABSTRACT

Session 3: Unique challenges of growing up with HIV

Michael Yin, MD

Bone Health among women aging with HIV

button_slides.png
button_video.png

New York State Psychiatric Institute & Columbia University, USA

Session 4: Healthy aging with HIV for women

Markella Zanni, MD

Cardiac Muscle Health Among Women Aging with HIV

button_slides.png
button_video.png

MGH/Harvard Medical School, USA

Session 4: Healthy aging with HIV for women

Marta Boffito, MD, PhD

Important Drug- Drug interactions in Women aging with HIV

button_slides.png
button_video.png

SSAT & Imperial College, Chelsea and Westminster Hospital, UK

Session 4: Healthy aging with HIV for women

Elisabeth McClymont

Non-Vaccine Oncogenic HPV Persistence Among HPV-Vaccinated Women Living with HIV

button_slides.png

University of British Columbia, Canada

ABSTRACT

Session 5: Research in women and HIV - 1

Angela Colbers, PhD

Dolutegravir pharmacokinetics during pregnancy and postpartum

button_slides.png

Radboud University Medical Center, The Netherlands

ABSTRACT

Session 5: Research in women and HIV - 1

Kalysha Closson

Intimate Partner Violence, Depression, and Mortality among a Cohort of Women living with HIV Marginalized by Socio-structural Inequities in Vancouver, Canada

button_slides.png

University Of British Columbia, Canada

ABSTRACT

Session 5: Research in women and HIV - 1

Melanie Nicol, PharmD, PhD

Vaginal microbiome and associations with tenofovir diphosphate and lamivudine triphosphate in cervical tissues of Ugandan women

button_slides.png

University of Minnesota, USA

ABSTRACT

Session 5: Research in women and HIV - 1

Daniel Kuritzkes, MD

HIV Cure: Where have we been, where are we going?

button_slides.png
button_video.png

Harvard Medical School, USA

Session 6: HIV cure research - considerations for women

Jintanat Ananworanich, MD, PhD

Invited lecture: Focus on women

button_slides.png
button_video.png

US Military HIV Research Program, USA

Session 6: HIV cure research - considerations for women

Romina Quercia, MD, PhD, MPH

Women’s involvement in clinical research: Women included in Dolutegravir clinical trials versus collaborative studies

button_slides.png

ViiV Healthcare, UK

ABSTRACT

Session 6: HIV cure research - considerations for women